ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.796,21
-0,68%
S&P 500
5.314,50
0,14%
US Dollar vs BRL
5,1521
-0,01%
Bitcoin
68.171,50
-1,35%
Brent Oil
81,48
-0,06%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. RegeneRX Biopharmaceuticals Inc (CE) (RGRX)

  7. RegeneRX Biopharmaceuticals Inc (CE) (RGRX) Notícias

RGRX

RegeneRX Biopharmaceutic... (CE) (RGRX)

RegeneRX Biopharmaceuticals Inc (CE)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:RGRX
DataHoraFonteTítuloCódigoCompanhia
14/08/202317:01Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
07/08/202316:57Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
11/07/202318:13Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
06/07/202317:35Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
06/07/202317:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
26/06/202307:01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
21/06/202307:03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
15/05/202317:25Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
11/04/202317:32Edgar (US Regulatory)Annual Report (10-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/05/202218:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
18/10/202107:05Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
17/08/202111:32Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/07/202117:16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
08/02/202120:29Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
16/10/202017:17Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
18/08/202007:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
10/09/201918:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
07/03/201916:15Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
01/03/201918:42Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
24/10/201807:02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
23/10/201807:05Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
12/12/201715:35Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
14/08/201718:10Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
03/08/201607:03Edgar (US Regulatory)(DEL AM)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
30/03/201618:17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
29/12/201416:42Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
01/04/201417:43Edgar (US Regulatory)Semi-annual Report (management Company) (nsar-a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
01/04/201417:43Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
01/04/201417:42Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
01/04/201417:37Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
 Apresentando as notícias mais relevantes sobre:USOTC:RGRX

Seu Histórico Recente

BIT
P1YOL9
NLBNPIT1YOL9 20240920 420
BIT
P21084
NLBNPIT21084 20351221 11...
BIT
P1X9F4
NLBNPIT1X9F4 20991231 22...
NYSE
NXE
NexGen Energy
NASDAQ
FLTCGX
Ftp Dividend Strength Po...
LSE
88CU
Mitsu Hc Cap 23
NASDAQ
FSVEX
Fidelity Advisor Sustain...
EU
RNO
Renault
BIT
P1X765
NLBNPIT1X765 20991231 2....
USOTC
AOIFF
Africa Oil (PK)
USOTC
GPFT
Grapefruit USA (PK)
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados